Anandamide
OwnerHugo Streekstrainventor
Life of this patent
Estimating the term…
Abstract
The present invention describes provides the use of anandamide for the manufacture of a nutraceutical for oral intake preferably a medicament for reducing appetite, giving a satiety effect, preventing or reducing inflammatory bowel disease or preventing or reducing irritable bowel syndrome
Claims10
The use of anandamide for the manufacture of a nutraceutical for oral intake preferably for reducing appetite, for giving a satiety effect, for preventing or reducing inflammatory bowel disease or for preventing or reducing irritable bowel syndrome.
The use of anandamide for reducing appetite, for giving a satiety effect, for preventing or reducing inflammatory bowel disease or for preventing or reducing irritable bowel syndrome.
A method of treatment for reducing appetite, for giving a satiety effect, for preventing or reducing inflammatory bowel disease or for preventing or reducing irritable bowel syndrome which comprises the oral administering anandamide to a subject in need of such treatment.
Anandamide for oral intake for reducing appetite, for giving a satiety effect, for preventing or reducing inflammatory bowel disease or for preventing or reducing irritable bowel syndrome.
A composition for oral intake comprising anandamide for reducing appetite, for giving a satiety effect, for preventing or reducing inflammatory bowel disease or for preventing or reducing irritable bowel syndrome.
A composition of comprising fatty acid ethanolamides of which anandamide constitutes more than 20 wt %, and preferably more than 80 Wt %.
Dependencies are inferred from the claim text.